Indoleamine 2,3 Dioxygenase 1 Market, Global Outlook and Forecast 2022-2028

Indoleamine 2,3 Dioxygenase 1 Market, Global Outlook and Forecast 2022-2028

Report Code: KNJ1281574 | No. of Pages: 73 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2022
This report contains market size and forecasts of Indoleamine 2,3 Dioxygenase 1 in global, including the following market information:
Global Indoleamine 2,3 Dioxygenase 1 Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Indoleamine 2,3 Dioxygenase 1 Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Indoleamine 2,3 Dioxygenase 1 companies in 2021 (%)
The global Indoleamine 2,3 Dioxygenase 1 market was valued at  million in 2021 and is projected to reach US$  million by 2028, at a CAGR of  % during the forecast period.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
BMS-986205 Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Indoleamine 2,3 Dioxygenase 1 include BirchBioMed Inc, Bristol-Myers Squibb Company, Ensemble Therapeutics Corp, F. Hoffmann-La Roche Ltd, Genentech Inc, Globavir Biosciences Inc, Incyte Corp, IO Biotech ApS and Kyowa Hakko Kirin, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Indoleamine 2,3 Dioxygenase 1 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Indoleamine 2,3 Dioxygenase 1 Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Indoleamine 2,3 Dioxygenase 1 Market Segment Percentages, by Type, 2021 (%)
    BMS-986205
    Dcellvax
    Epacadostat
    F-001287
    Galanal
    Others
Global Indoleamine 2,3 Dioxygenase 1 Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Indoleamine 2,3 Dioxygenase 1 Market Segment Percentages, by Application, 2021 (%)
    Aolpecia
    Cervical Cancer
    Gastric Cancer
    Glioma
    Others
Global Indoleamine 2,3 Dioxygenase 1 Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Indoleamine 2,3 Dioxygenase 1 Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Indoleamine 2,3 Dioxygenase 1 revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Indoleamine 2,3 Dioxygenase 1 revenues share in global market, 2021 (%)
Key companies Indoleamine 2,3 Dioxygenase 1 sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Indoleamine 2,3 Dioxygenase 1 sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    BirchBioMed Inc
    Bristol-Myers Squibb Company
    Ensemble Therapeutics Corp
    F. Hoffmann-La Roche Ltd
    Genentech Inc
    Globavir Biosciences Inc
    Incyte Corp
    IO Biotech ApS
    Kyowa Hakko Kirin
    Netherlands Translational Research Center BV
    NewLink Genetics Corp
    Pfizer Inc
    Redx Pharma Plc
    Regen BioPharma Inc
1 Introduction to Research & Analysis Reports
    1.1 Indoleamine 2,3 Dioxygenase 1 Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Indoleamine 2,3 Dioxygenase 1 Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Indoleamine 2,3 Dioxygenase 1 Overall Market Size
    2.1 Global Indoleamine 2,3 Dioxygenase 1 Market Size: 2021 VS 2028
    2.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global Indoleamine 2,3 Dioxygenase 1 Sales: 2017-2028
3 Company Landscape
    3.1 Top Indoleamine 2,3 Dioxygenase 1 Players in Global Market
    3.2 Top Global Indoleamine 2,3 Dioxygenase 1 Companies Ranked by Revenue
    3.3 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Companies
    3.4 Global Indoleamine 2,3 Dioxygenase 1 Sales by Companies
    3.5 Global Indoleamine 2,3 Dioxygenase 1 Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 Indoleamine 2,3 Dioxygenase 1 Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers Indoleamine 2,3 Dioxygenase 1 Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Indoleamine 2,3 Dioxygenase 1 Players in Global Market
        3.8.1 List of Global Tier 1 Indoleamine 2,3 Dioxygenase 1 Companies
        3.8.2 List of Global Tier 2 and Tier 3 Indoleamine 2,3 Dioxygenase 1 Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Indoleamine 2,3 Dioxygenase 1 Market Size Markets, 2021 & 2028
        4.1.2 BMS-986205
        4.1.3 Dcellvax
        4.1.4 Epacadostat
        4.1.5 F-001287
        4.1.6 Galanal
        4.1.7 Others
    4.2 By Type - Global Indoleamine 2,3 Dioxygenase 1 Revenue & Forecasts
        4.2.1 By Type - Global Indoleamine 2,3 Dioxygenase 1 Revenue, 2017-2022
        4.2.2 By Type - Global Indoleamine 2,3 Dioxygenase 1 Revenue, 2023-2028
        4.2.3 By Type - Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share, 2017-2028
    4.3 By Type - Global Indoleamine 2,3 Dioxygenase 1 Sales & Forecasts
        4.3.1 By Type - Global Indoleamine 2,3 Dioxygenase 1 Sales, 2017-2022
        4.3.2 By Type - Global Indoleamine 2,3 Dioxygenase 1 Sales, 2023-2028
        4.3.3 By Type - Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share, 2017-2028
    4.4 By Type - Global Indoleamine 2,3 Dioxygenase 1 Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global Indoleamine 2,3 Dioxygenase 1 Market Size, 2021 & 2028
        5.1.2 Aolpecia
        5.1.3 Cervical Cancer
        5.1.4 Gastric Cancer
        5.1.5 Glioma
        5.1.6 Others
    5.2 By Application - Global Indoleamine 2,3 Dioxygenase 1 Revenue & Forecasts
        5.2.1 By Application - Global Indoleamine 2,3 Dioxygenase 1 Revenue, 2017-2022
        5.2.2 By Application - Global Indoleamine 2,3 Dioxygenase 1 Revenue, 2023-2028
        5.2.3 By Application - Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share, 2017-2028
    5.3 By Application - Global Indoleamine 2,3 Dioxygenase 1 Sales & Forecasts
        5.3.1 By Application - Global Indoleamine 2,3 Dioxygenase 1 Sales, 2017-2022
        5.3.2 By Application - Global Indoleamine 2,3 Dioxygenase 1 Sales, 2023-2028
        5.3.3 By Application - Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share, 2017-2028
    5.4 By Application - Global Indoleamine 2,3 Dioxygenase 1 Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global Indoleamine 2,3 Dioxygenase 1 Market Size, 2021 & 2028
    6.2 By Region - Global Indoleamine 2,3 Dioxygenase 1 Revenue & Forecasts
        6.2.1 By Region - Global Indoleamine 2,3 Dioxygenase 1 Revenue, 2017-2022
        6.2.2 By Region - Global Indoleamine 2,3 Dioxygenase 1 Revenue, 2023-2028
        6.2.3 By Region - Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share, 2017-2028
    6.3 By Region - Global Indoleamine 2,3 Dioxygenase 1 Sales & Forecasts
        6.3.1 By Region - Global Indoleamine 2,3 Dioxygenase 1 Sales, 2017-2022
        6.3.2 By Region - Global Indoleamine 2,3 Dioxygenase 1 Sales, 2023-2028
        6.3.3 By Region - Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America Indoleamine 2,3 Dioxygenase 1 Revenue, 2017-2028
        6.4.2 By Country - North America Indoleamine 2,3 Dioxygenase 1 Sales, 2017-2028
        6.4.3 US Indoleamine 2,3 Dioxygenase 1 Market Size, 2017-2028
        6.4.4 Canada Indoleamine 2,3 Dioxygenase 1 Market Size, 2017-2028
        6.4.5 Mexico Indoleamine 2,3 Dioxygenase 1 Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe Indoleamine 2,3 Dioxygenase 1 Revenue, 2017-2028
        6.5.2 By Country - Europe Indoleamine 2,3 Dioxygenase 1 Sales, 2017-2028
        6.5.3 Germany Indoleamine 2,3 Dioxygenase 1 Market Size, 2017-2028
        6.5.4 France Indoleamine 2,3 Dioxygenase 1 Market Size, 2017-2028
        6.5.5 U.K. Indoleamine 2,3 Dioxygenase 1 Market Size, 2017-2028
        6.5.6 Italy Indoleamine 2,3 Dioxygenase 1 Market Size, 2017-2028
        6.5.7 Russia Indoleamine 2,3 Dioxygenase 1 Market Size, 2017-2028
        6.5.8 Nordic Countries Indoleamine 2,3 Dioxygenase 1 Market Size, 2017-2028
        6.5.9 Benelux Indoleamine 2,3 Dioxygenase 1 Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia Indoleamine 2,3 Dioxygenase 1 Revenue, 2017-2028
        6.6.2 By Region - Asia Indoleamine 2,3 Dioxygenase 1 Sales, 2017-2028
        6.6.3 China Indoleamine 2,3 Dioxygenase 1 Market Size, 2017-2028
        6.6.4 Japan Indoleamine 2,3 Dioxygenase 1 Market Size, 2017-2028
        6.6.5 South Korea Indoleamine 2,3 Dioxygenase 1 Market Size, 2017-2028
        6.6.6 Southeast Asia Indoleamine 2,3 Dioxygenase 1 Market Size, 2017-2028
        6.6.7 India Indoleamine 2,3 Dioxygenase 1 Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America Indoleamine 2,3 Dioxygenase 1 Revenue, 2017-2028
        6.7.2 By Country - South America Indoleamine 2,3 Dioxygenase 1 Sales, 2017-2028
        6.7.3 Brazil Indoleamine 2,3 Dioxygenase 1 Market Size, 2017-2028
        6.7.4 Argentina Indoleamine 2,3 Dioxygenase 1 Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Sales, 2017-2028
        6.8.3 Turkey Indoleamine 2,3 Dioxygenase 1 Market Size, 2017-2028
        6.8.4 Israel Indoleamine 2,3 Dioxygenase 1 Market Size, 2017-2028
        6.8.5 Saudi Arabia Indoleamine 2,3 Dioxygenase 1 Market Size, 2017-2028
        6.8.6 UAE Indoleamine 2,3 Dioxygenase 1 Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 BirchBioMed Inc
        7.1.1 BirchBioMed Inc Corporate Summary
        7.1.2 BirchBioMed Inc Business Overview
        7.1.3 BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Major Product Offerings
        7.1.4 BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Sales and Revenue in Global (2017-2022)
        7.1.5 BirchBioMed Inc Key News
    7.2 Bristol-Myers Squibb Company
        7.2.1 Bristol-Myers Squibb Company Corporate Summary
        7.2.2 Bristol-Myers Squibb Company Business Overview
        7.2.3 Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Major Product Offerings
        7.2.4 Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Sales and Revenue in Global (2017-2022)
        7.2.5 Bristol-Myers Squibb Company Key News
    7.3 Ensemble Therapeutics Corp
        7.3.1 Ensemble Therapeutics Corp Corporate Summary
        7.3.2 Ensemble Therapeutics Corp Business Overview
        7.3.3 Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Major Product Offerings
        7.3.4 Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Sales and Revenue in Global (2017-2022)
        7.3.5 Ensemble Therapeutics Corp Key News
    7.4 F. Hoffmann-La Roche Ltd
        7.4.1 F. Hoffmann-La Roche Ltd Corporate Summary
        7.4.2 F. Hoffmann-La Roche Ltd Business Overview
        7.4.3 F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Major Product Offerings
        7.4.4 F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Sales and Revenue in Global (2017-2022)
        7.4.5 F. Hoffmann-La Roche Ltd Key News
    7.5 Genentech Inc
        7.5.1 Genentech Inc Corporate Summary
        7.5.2 Genentech Inc Business Overview
        7.5.3 Genentech Inc Indoleamine 2,3 Dioxygenase 1 Major Product Offerings
        7.5.4 Genentech Inc Indoleamine 2,3 Dioxygenase 1 Sales and Revenue in Global (2017-2022)
        7.5.5 Genentech Inc Key News
    7.6 Globavir Biosciences Inc
        7.6.1 Globavir Biosciences Inc Corporate Summary
        7.6.2 Globavir Biosciences Inc Business Overview
        7.6.3 Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Major Product Offerings
        7.6.4 Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Sales and Revenue in Global (2017-2022)
        7.6.5 Globavir Biosciences Inc Key News
    7.7 Incyte Corp
        7.7.1 Incyte Corp Corporate Summary
        7.7.2 Incyte Corp Business Overview
        7.7.3 Incyte Corp Indoleamine 2,3 Dioxygenase 1 Major Product Offerings
        7.7.4 Incyte Corp Indoleamine 2,3 Dioxygenase 1 Sales and Revenue in Global (2017-2022)
        7.7.5 Incyte Corp Key News
    7.8 IO Biotech ApS
        7.8.1 IO Biotech ApS Corporate Summary
        7.8.2 IO Biotech ApS Business Overview
        7.8.3 IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Major Product Offerings
        7.8.4 IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Sales and Revenue in Global (2017-2022)
        7.8.5 IO Biotech ApS Key News
    7.9 Kyowa Hakko Kirin
        7.9.1 Kyowa Hakko Kirin Corporate Summary
        7.9.2 Kyowa Hakko Kirin Business Overview
        7.9.3 Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Major Product Offerings
        7.9.4 Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Sales and Revenue in Global (2017-2022)
        7.9.5 Kyowa Hakko Kirin Key News
    7.10 Netherlands Translational Research Center BV
        7.10.1 Netherlands Translational Research Center BV Corporate Summary
        7.10.2 Netherlands Translational Research Center BV Business Overview
        7.10.3 Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Major Product Offerings
        7.10.4 Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Sales and Revenue in Global (2017-2022)
        7.10.5 Netherlands Translational Research Center BV Key News
    7.11 NewLink Genetics Corp
        7.11.1 NewLink Genetics Corp Corporate Summary
        7.11.2 NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Business Overview
        7.11.3 NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Major Product Offerings
        7.11.4 NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Sales and Revenue in Global (2017-2022)
        7.11.5 NewLink Genetics Corp Key News
    7.12 Pfizer Inc
        7.12.1 Pfizer Inc Corporate Summary
        7.12.2 Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Business Overview
        7.12.3 Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Major Product Offerings
        7.12.4 Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Sales and Revenue in Global (2017-2022)
        7.12.5 Pfizer Inc Key News
    7.13 Redx Pharma Plc
        7.13.1 Redx Pharma Plc Corporate Summary
        7.13.2 Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Business Overview
        7.13.3 Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Major Product Offerings
        7.13.4 Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Sales and Revenue in Global (2017-2022)
        7.13.5 Redx Pharma Plc Key News
    7.14 Regen BioPharma Inc
        7.14.1 Regen BioPharma Inc Corporate Summary
        7.14.2 Regen BioPharma Inc Business Overview
        7.14.3 Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Major Product Offerings
        7.14.4 Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Sales and Revenue in Global (2017-2022)
        7.14.5 Regen BioPharma Inc Key News
8 Global Indoleamine 2,3 Dioxygenase 1 Production Capacity, Analysis
    8.1 Global Indoleamine 2,3 Dioxygenase 1 Production Capacity, 2017-2028
    8.2 Indoleamine 2,3 Dioxygenase 1 Production Capacity of Key Manufacturers in Global Market
    8.3 Global Indoleamine 2,3 Dioxygenase 1 Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Indoleamine 2,3 Dioxygenase 1 Supply Chain Analysis
    10.1 Indoleamine 2,3 Dioxygenase 1 Industry Value Chain
    10.2 Indoleamine 2,3 Dioxygenase 1 Upstream Market
    10.3 Indoleamine 2,3 Dioxygenase 1 Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Indoleamine 2,3 Dioxygenase 1 Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com